Safety and Efficacy Study of Dysport RU and Glabellar Lines
- 12 septembre 2024 - 1 mn de lecture
The primary objective is to assess the dose response versus placebo of a single treatment of Dysport RU (Dysport RU, Ready to Use, for injection), for the improvement in appearance of moderate to severe glabellar lines at maximum frown.
12 septembre 2024
1 mn de lecture
An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in People With Fibrodysplasia Ossificans Progressiva (FOP) in France
12 septembre 2024
1 mn de lecture
An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)
12 septembre 2024
1 mn de lecture
Evaluation of Palovarotene Concentration in Semen of Healthy Men after Multiple Oral Doses
12 septembre 2024
1 mn de lecture
A Thorough QT Study Evaluating the Effect of a Therapeutic and a Supratherapeutic Dose of Palovarotene on Electrocardiogram Parameters
12 septembre 2024
1 mn de lecture
Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in...
12 septembre 2024
1 mn de lecture
68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
12 septembre 2024
1 mn de lecture
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
12 septembre 2024
1 mn de lecture
Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency
12 septembre 2024
1 mn de lecture
Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
12 septembre 2024
1 mn de lecture